scholarly article | Q13442814 |
P2093 | author name string | Paul Z. Gerczuk | |
Robert A. Kloner | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 969-78 | |
P577 | publication date | 2012-03-13 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials | |
P478 | volume | 59 |
Q91596508 | A novel small molecule compound VCP979 improves ventricular remodeling in murine models of myocardial ischemia/reperfusion injury |
Q36352289 | A screen for protective drugs against delayed hypoxic injury |
Q60907401 | A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats |
Q44954168 | Activated platelet supernatant can augment the angiogenic potential of human peripheral blood stem cells mobilized from bone marrow by G-CSF. |
Q33676193 | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET |
Q36321702 | Adaptive response, evidence of cross-resistance and its potential clinical use |
Q34137983 | Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling. |
Q47346466 | Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion. |
Q47108502 | Apelin protects against myocardial ischemic injury by inhibiting dynamin-related protein 1. |
Q45291527 | Approaches to Improving Cardiac Structure and Function During and After an Acute Myocardial Infarction: Acute and Chronic Phases |
Q55269049 | Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats. |
Q54321977 | Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. |
Q64239467 | Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction |
Q48833015 | Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery |
Q26765120 | Building and re-building the heart by cardiomyocyte proliferation |
Q35186568 | Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury |
Q38124357 | Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives |
Q37298516 | Cardioprotection and myocardial reperfusion: pitfalls to clinical application |
Q30244797 | Cardioprotection: Where to from here? |
Q30359782 | Cell therapy for cardiac repair--lessons from clinical trials. |
Q89964178 | Clemastine Fumarate Protects Against Myocardial Ischemia Reperfusion Injury by Activating the TLR4/PI3K/Akt Signaling Pathway |
Q90249431 | Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel |
Q40025016 | Cyclosporine-A mimicked the ischemic pre- and postconditioning-mediated cardioprotection in hypertensive rats: Role of PKCε. |
Q41248810 | Distribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion Injury |
Q58563307 | Effect of CCR2 inhibitor-loaded lipid micelles on inflammatory cell migration and cardiac function after myocardial infarction |
Q50612820 | Effect of remote ischemic postconditioning on left ventricular mechanics. |
Q35806794 | Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials |
Q37199307 | Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue |
Q46895349 | Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models |
Q54456353 | Extracellular matrix protein CCN1 regulates cardiomyocyte apoptosis in mice with stress-induced cardiac injury. |
Q46809432 | Hes1 is upregulated by ischemic postconditioning and contributes to cardioprotection |
Q38038533 | Imaging the myocardial microcirculation post-myocardial infarction |
Q90347777 | Inducing Endogenous Cardiac Regeneration: Can Biomaterials Connect the Dots? |
Q34104323 | Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair |
Q26853129 | Ischaemic postconditioning: cardiac protection after the event |
Q37668843 | Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists |
Q92960020 | Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p |
Q44792216 | Magnesium orotate elicits acute cardioprotection at reperfusion in isolated and in vivo rat hearts |
Q47382623 | Measurement of myocardial perfusion and infarction size using computer-aided diagnosis system for myocardial contrast echocardiography |
Q38069136 | Mesenchymal stem cells and kidney repair |
Q50975110 | Mitochondria in Ischemic Heart Disease. |
Q61443749 | Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats |
Q38244750 | Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury |
Q41969280 | Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction |
Q55383231 | Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects. |
Q38370165 | Neuroprotection in stroke: the importance of collaboration and reproducibility. |
Q45064238 | New and revisited approaches to preserving the reperfused myocardium |
Q37368561 | Notch signaling activation contributes to cardioprotection provided by ischemic preconditioning and postconditioning |
Q33812924 | Novel adjunctive treatments of myocardial infarction |
Q34276258 | Novel therapeutic strategies for ischemic heart disease |
Q50568281 | Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats. |
Q33897916 | Oxygen sensing strategies in mammals and bacteria. |
Q37241166 | Pathological ventricular remodeling: mechanisms: part 1 of 2 |
Q37499879 | Phosphomimetic modulation of eNOS improves myocardial reperfusion and mimics cardiac postconditioning in mice. |
Q58126997 | Postinfarction Hearts Are Protected by Premature Senescent Cardiomyocytes Via GATA 4-Dependent CCN 1 Secretion |
Q36190291 | Protection of the ischemic myocardium during the reperfusion: between hope and reality. |
Q89341498 | Protective effect of morin on myocardial ischemia‑reperfusion injury in rats |
Q41520413 | Protective effects of Araloside C against myocardial ischaemia/reperfusion injury: potential involvement of heat shock protein 90. |
Q64103243 | Protective effects of Myrica rubra flavonoids against hypoxia/reoxygenation-induced cardiomyocyte injury via the regulation of the PI3K/Akt/GSK3β pathway |
Q38377285 | Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease |
Q91909003 | Rationale and Design of the High Platelet Inhibition with Ticagrelor to Improve Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction (HEALING-AMI) Trial |
Q60913018 | Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation |
Q27022906 | Regenerative principles enrich cardiac rehabilitation practice |
Q35892642 | Remote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium |
Q38249023 | Remote conditioning the heart overview: translatability and mechanism |
Q38344695 | Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials |
Q93182863 | SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion |
Q87164623 | Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction |
Q38710888 | Small Interfering RNA Targeting Mitochondrial Calcium Uniporter Improves Cardiomyocyte Cell Viability in Hypoxia/Reoxygenation Injury by Reducing Calcium Overload. |
Q37746255 | Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats |
Q47571628 | Targeting Hypoxia Signaling for Perioperative Organ Injury |
Q55384244 | The Oxygen Paradox, the French Paradox, and age-related diseases. |
Q27026299 | The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria |
Q52584740 | Therapeutic Potential of a Novel Necrosis Inhibitor, 7-Amino-Indole, in Myocardial Ischemia-Reperfusion Injury. |
Q38099380 | Ticagrelor: positive, negative and misunderstood properties as a new antiplatelet agent |
Q64272574 | Treatment with metformin prevents myocardial ischemia-reperfusion injury via STEAP4 signaling pathway |
Q26864088 | Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease |
Q37397458 | Water-soluble acacetin prodrug confers significant cardioprotection against ischemia/reperfusion injury |
Q90676339 | circDLPAG4/HECTD1 mediates ischaemia/reperfusion injury in endothelial cells via ER stress |
Q47141477 | miR-19a protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt pathway |
Q54343158 | β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. |
Search more.